Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2021-10-06
Original market date: See footnote 1
2015-11-02
Product name:
OSURNIA
DIN:
02438534
Product Monograph/Veterinary Labelling:
Date:
2024-02-15
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
DECHRA LTD
Snaygill Industrial Estate, Keighley Road
Skipton
North Yorkshire
United Kingdom
BD23 2RW
Class:
Veterinary
Species:
Dogs
Dosage form(s):
Gel
Route(s) of administration:
Otic
Number of active ingredient(s):
3
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
Anatomical Therapeutic Chemical (ATC): See footnote 4
Not Applicable
Active ingredient group (AIG) number:See footnote5
0356670001
| Active ingredient(s) | Strength |
|---|---|
| BETAMETHASONE ACETATE | 1 MG / ML |
| FLORFENICOL | 10 MG / ML |
| TERBINAFINE | 10 MG / ML |